🔎 Trials Near Me

Početna › Tumori mozga › Illinois

Kliničke studije za Tumori mozga u državi Illinois

14 studija za Tumori mozga traži sudionike na lokacijama u državi Illinois.

Gradovi u državi Illinois

Službeni tekst studije (engleski)

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • Saint Anthony's Health, Alton
  • Rush - Copley Medical Center, Aurora
  • Illinois CancerCare-Bloomington, Bloomington
  • i još 33
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 15. ruj 2026. · NCT04511013

Frameless Stereotactic Radiosurgery for Intact Brain Metastases

  • University of Chicago, Chicago
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT02747303

A Phase 1/1b Study of IAM1363 in HER2 Cancers

  • University of Chicago, Chicago
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT06253871

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

  • Carle Cancer Center, Urbana
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 9. ruj 2026. · NCT05386108

Targeted Pediatric High-Grade Glioma Therapy

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
U tijeku regrutacijaOpažajna studija
12 Months – 39 Years · Oba spola · Ažurirano 8. ruj 2026. · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
U tijeku regrutacijaFaza 2
Od 12 do 39 godina · Oba spola · Ažurirano 1. ruj 2026. · NCT06161974

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

  • Robert H. Lurie Comprehensive Cancer Center Northwestern University, Chicago
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 21. kol 2026. · NCT06764940

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

  • Lurie Children's Hospital, Chicago
U tijeku regrutacijaFaza 2
Od 1 do 26 godina · Oba spola · Ažurirano 4. kol 2026. · NCT07680439

REMASTer: REcurrent Brain Metastases After SRS Trial

  • University of Chicago, Chicago
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 18. lip 2026. · NCT05124912

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

  • Decatur Memorial Hospital, Decatur
  • HSHS Saint Elizabeth's Hospital, O'Fallon
  • Methodist Medical Center of Illinois, Peoria
  • i još 2
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 9. lip 2026. · NCT03550391

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
U tijeku regrutacijaFaza 2
12 Months – 39 Years · Oba spola · Ažurirano 29. svi 2026. · NCT05843253

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • Northwestern Memorial Hospital, Chicago
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 13. tra 2026. · NCT06810544

Intraoperative Fluorescence-Guided Aspirate Tissue Monitoring of 5-ALA During Brain Tumor Surgery

  • University of Illinois at Chicago, Chicago
U tijeku regrutacija
Od 18 do 99 godina · Oba spola · Ažurirano 12. stu 2025. · NCT07111182

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

  • John H Stroger Jr Hospital of Cook County, Chicago
  • Decatur Memorial Hospital, Decatur
  • Loyola University Medical Center, Maywood
  • i još 1
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 8. lis 2025. · NCT03418961

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.